The clinical utility and prognostic value of next-generation sequencing for measurable residual disease assessment in acute myeloid leukemia

The clinical utility and prognostic value of next-generation sequencing for measurable residual disease assessment in acute myeloid leukemia

Background: Next-generation sequencing (NGS) offers a method for measurable residual disease (MRD) assessment by detecting leukemia-associated genetic mutations. Objective: This study aimed to evaluate the clinical implications and prognostic value of NGS-based MRD assessment in acute myeloid leukem...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu Liu, Huanchen Cheng, Meng Sun, Tiejun Gong, Jun Ma
Format: Article
Language:English
Published: SAGE Publishing 2025-06-01
Series:Therapeutic Advances in Hematology
Online Access:https://doi.org/10.1177/20406207251349261
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items